human
coronavirus
respiratori
pathogen
zoonot
origin
gain
worldwid
distribut
appar
emerg
bovin
coronaviru
bcov
spillov
three
virus
attach
sialoglycan
via
spike
protein
hemagglutininesteras
act
receptordestroy
enzym
bcov
lectin
domain
promot
esteras
activ
toward
cluster
substrat
howev
lost
lectin
function
adapt
human
replay
evolut
knockedout
bcov
lectin
function
perform
forc
evolutionpopul
ynamic
analysi
loss
receptorbind
select
secondsit
mutat
decreas
bind
affin
order
magnitud
irrevers
mutat
select
cooper
viru
swarm
lowaffin
minor
variant
sustain
propag
highaffin
major
phenotyp
salvag
mutat
induc
success
secondsit
substitut
appar
function
interdepend
coevolv
optim
balanc
attach
releas
mechan
glycanbas
receptor
usag
entail
concert
finetun
activ
two
envelop
protein
speci
uniqu
among
cov
reminisc
influenza
virus
iav
appar
gener
principl
fundament
virionsialoglycan
interact
prompt
converg
evolut
two
import
group
human
anim
pathogen
subfamili
orthocoronavirina
compris
group
envelop
positivestrand
rna
virus
clinic
veterinari
signific
ad
socioeconom
impact
coronavirus
cov
alreadi
extant
human
livestock
emerg
new
cov
cross
speci
transmiss
pose
everloom
threat
public
health
anim
health
food
product
seven
coronavirus
known
infect
human
becom
establish
introduct
sar
cov
horsesho
bat
mask
palm
civet
incident
transient
host
rapidli
contain
quarantin
measur
mer
cov
natur
dromedari
camel
caus
classic
zoonot
infect
limit
humantohuman
spread
decemb
member
speci
sever
acut
respiratori
syndrom
relat
coronaviru
sarscov
call
ident
sar
cov
variant
emerg
wuhan
china
progress
full
scale
pandem
chanc
eventu
becom
establish
human
popul
four
respiratori
coronavirus
zoonot
origin
alreadi
succeed
becom
true
human
virus
worldwid
distribut
among
subgenu
embecoviru
genu
betacoronaviru
relat
yet
distinct
virus
aros
differ
zoonot
progenitor
enter
human
popul
independ
far
relat
bovin
coronaviru
bcov
presumpt
ancestor
earli
isol
share
genom
ident
togeth
virus
swine
canin
equin
lagomorph
bcov
consid
host
rang
variant
viru
speci
collect
refer
throughout
appar
emerg
year
ago
singl
cross
speci
transmiss
event
gave
rise
viru
like
also
exhibit
host
specif
observ
attest
host
promiscu
zoonot
potenti
embecovirus
particular
also
indic
exist
host
barrier
breach
select
adapt
mutat
result
host
special
ultim
viru
speciat
conceiv
compar
studi
authorfund
right
reserv
reus
allow
without
permiss
biorxiv
preprint
bcov
may
identifi
factor
promot
restrict
cross
speci
transmiss
cov
thu
understand
requir
colon
human
host
embecovirus
bcov
includ
differ
cov
encod
two
type
surfac
project
homotrimer
peplom
compris
spike
protein
extend
nm
viral
membran
mediat
virion
attach
entri
receptor
membran
fusion
interspers
stubbi
homodimer
project
compris
hemagglutininesteras
dual
function
protein
typic
encompass
receptorbind
lectin
domain
specif
oacetyl
sialic
acid
oacsia
receptor
destroy
sialateoacetylesteras
domain
lectin
domain
contribut
virion
attach
time
enhanc
acetylesteras
activ
toward
cluster
sialoglycotop
embecovirus
like
mous
hepat
viru
mhv
relat
cov
rodent
attach
oacetyl
sialosid
via
proteinac
entri
receptor
via
other
anim
includ
bind
via
remark
also
via
case
human
coronavirus
even
exclus
via
structur
function
analys
protein
yield
wealth
data
ligand
bind
substrat
select
proteinglycan
interact
receptor
bind
site
rbss
cov
lectin
domain
relat
protein
toroand
influenza
cd
virus
differ
sequenc
structur
yet
conform
common
architectur
design
deep
hydrophob
pocket
accommod
crucial
sialateoacetyl
moieti
adjac
pocket
depress
accept
group
characterist
separ
aromat
side
chain
bind
ligand
stabil
electrostat
proteinglycan
interact
typic
involv
distinct
sia
function
sia
glycerol
side
chain
andor
sia
carboxyl
rb
protein
bcov
identifi
compar
structur
analysi
confirm
cryoem
holostructur
conform
blueprint
moreov
site
structur
function
conserv
biorxiv
preprint
much
less
known
function
relationship
role
particular
remain
poorli
understood
mhv
express
dispens
replic
rapidli
lost
cell
cultur
propag
convers
seem
critic
infect
loss
heassoci
acetyl
esteras
activ
abrog
product
infecti
viru
viru
dissemin
cell
cultur
moreov
acetylesteras
inhibitor
imped
bcov
replic
antibodi
neutral
viru
vitro
vivo
still
even
among
differ
function
appar
correl
host
specif
wherea
lectin
activ
strictli
maintain
bcov
lost
function
progress
accumul
mutat
rb
appar
adapt
replic
human
respiratori
tract
nevertheless
isol
either
viru
propag
cultur
cell
better
understand
consequ
loss
lectin
function
occur
also
evolut
took
revers
geneticsforc
evolut
approach
bcov
model
find
reveal
function
interdepend
acquisit
protoembecoviru
allow
descend
adopt
strategi
revers
virionsialoglycan
attach
remark
similar
influenza
virus
result
disrupt
lectin
function
select
mutat
studi
role
import
propag
develop
revers
genet
system
bcov
strain
mebu
sfig
base
target
rna
recombin
recombin
wildtyp
bcov
rbcov
parent
type
accessori
replac
renilla
luciferas
gene
rbcovrluc
readili
gener
upon
seed
acceptorvirusinfect
donor
rnatransfect
mous
cell
onto
monolay
feeder
cell
rbcovrluc
aros
within
seven
day
grew
final
titer
routin
obtain
wildtyp
bcov
gener
bcovrluc
deriv
defect
lectin
function
prove
cumbersom
abolish
rb
substitut
phe
key
ligand
bind
sfig
ala
via
two
nucleotid
substitut
block
revers
mutant
virus
recov
eventu
success
trial
multistep
rescu
suffic
addit
hr
blind
passag
requir
fig
sequenc
analysi
clonal
viru
popul
obtain
endpoint
dilut
confirm
presenc
phe
ala
substitut
case
surprisingli
purifi
virus
suffer
singl
site
mutat
cluster
domain
aa
proxim
rb
fig
sfig
two
trial
yield
multipl
variant
variant
thr
ile
leu
proemerg
independ
separ
experi
fig
mutat
map
three
distinct
rb
element
fig
sfig
nomenclatur
accord
ile
ser
asn
ser
locat
element
within
ntermin
segment
aa
wall
pocket
crucial
ligand
bind
accommod
allimport
moieti
moreov
cryoem
holostructur
asn
side
chain
hydrogen
bond
carbonyl
leu
pro
element
immedi
adjac
trp
latter
arguabl
critic
residu
rb
indol
side
chain
separ
pocket
replac
preclud
bind
viru
infect
final
gli
glu
thr
ile
substitut
occur
element
interact
sialat
carboxyl
hydrogen
bond
ly
thr
biorxiv
preprint
measur
solid
phase
lectin
bind
assay
splba
fc
fusion
protein
bovin
submaxillari
mucin
bsm
ligand
mutat
significantli
reduc
bind
albeit
wide
differ
extent
fc
bind
affin
mutant
asn
ser
ile
ser
gli
glu
lower
parent
bcov
fc
fig
loss
lectin
rb
would
abolish
heassist
virion
attach
receptor
determin
well
reduc
virionassoci
receptordestroy
sialateoacetylesteras
activ
toward
cluster
glycotop
find
suggest
heph
ala
substitut
creat
fit
defect
allevi
increas
dramat
reduc
affin
rb
thu
defect
appar
caus
loss
virionassoci
rde
activ
rather
loss
overal
virion
avid
downregul
esteras
activ
consequenti
loss
lectin
function
could
affect
viru
propag
two
stage
infecti
cycl
name
viru
releas
would
requir
deplet
intracellular
cell
surfac
receptor
pool
pre
attach
recent
report
defici
vesicular
stomat
vsv
virion
pseudotyp
wildtyp
bcov
requir
exogen
effici
infect
mutat
reduc
affin
inhibit
infect
show
present
vsv
virion
pseudotyp
low
affin
mutant
protein
less
reliant
even
inhibit
exogen
decreas
rb
affin
fig
find
provid
direct
proof
mutat
act
level
virion
attach
support
notion
mutat
select
hedefect
rbcov
restor
revers
receptor
bind
lower
affin
therebi
protect
inadvert
attach
decoy
receptor
lectindefici
recombin
bcov
genet
stabl
grown
presenc
exogen
receptordestroy
enzym
test
whether
loss
virionassoci
rde
activ
rbcovhef
wt
rluc
might
compens
ad
exogen
solubl
cultur
medium
seed
infectedtransfect
cell
onto
cell
monolay
supplement
authorfund
right
reserv
reus
allow
without
permiss
biorxiv
preprint
promot
viru
growth
fig
determin
whether
condit
would
allow
isol
rbcovhef
without
mutat
perform
target
recombin
rescu
recombin
virus
hr
multistep
propag
cultur
supernat
supplement
ngml
hefc
fig
sanger
sequenc
analysi
rtpcr
amplicon
show
virus
clone
endpoint
dilut
stock
code
mutant
heph
ala
combin
wildtyp
assess
stabil
clonal
rbcovhef
wt
rluc
viru
popul
result
subsequ
hr
amplif
presenc
exogen
hefc
analyz
nextgener
sequenc
ng
allow
detect
low
frequenc
mutant
sequenc
variat
distribut
randomli
exceed
background
level
virus
code
heph
ala
preserv
parent
type
fig
among
affin
variant
clonal
virtual
pure
stock
rbcovhef
wt
avail
perform
control
forc
evolut
experi
viru
serial
passag
involv
three
consecut
multistep
propag
round
cell
absenc
exogen
hefc
initi
infect
multipl
infect
moi
fig
trial
viral
titer
passag
increas
slowli
x
x
measur
without
exogen
hefc
respect
withdraw
exogen
rde
viral
passag
immedi
select
mutat
viru
clone
endpoint
dilut
sampl
yield
rb
mutant
asn
ser
thr
ile
ile
ser
fig
three
seen
fig
ng
analysi
reveal
true
complex
popul
fig
identifi
two
addit
variant
substitut
tyr
arg
cysmor
distal
rb
sfig
b
tyr
also
reduc
rel
bind
affin
fc
albeit
less
dramat
authorfund
right
reserv
reus
allow
without
permiss
biorxiv
preprint
mutat
name
tabl
arg
cy
mutat
seemingli
fall
separ
categori
reduc
fc
express
level
suggest
defect
fold
sfig
appar
aberr
disulfidebond
caus
fusion
protein
retain
er
minor
presum
properli
fold
fraction
slip
becom
secret
popul
compris
virtual
heph
ala
mutant
combin
parent
bcov
remain
secondsit
mutat
fig
tabl
latter
ultralow
affin
variant
ile
ser
abund
asn
ser
variant
least
less
howev
upon
subsequ
round
multistep
propag
tabl
turn
asn
ser
compris
almost
popul
ile
ser
variant
reduc
addit
four
variant
emerg
one
mutat
rb
loop
val
gli
rel
bind
affin
close
asn
ser
mutant
fig
tabl
also
identifi
posit
second
cyssubstitut
mutant
like
arg
cy
presum
disrupt
rb
aberr
disulfid
bond
sfig
remark
two
variant
aros
mutat
arg
thr
pro
leuthat
affect
rel
bind
affin
modestli
wildtyp
fc
respect
tabl
even
remark
upon
passag
mutant
increas
domin
popul
effect
outcompet
variant
low
affin
spike
well
parent
spike
fig
howev
stock
clone
endpoint
dilut
absenc
exogen
hefc
viru
variant
low
affin
mutat
isol
fig
cell
cultur
supernat
bcov
hefc
final
concentr
pg
allow
infect
proceed
hr
absenc
hefc
sign
viru
propag
detect
ifa
concentr
exogen
sialateoacetylesteras
low
ngml
frequenc
result
mutat
lectin
affin
regain
albeit
level
sole
detect
highsensit
nanobead
hemagglutin
assay
esteras
activ
toward
cluster
glycotop
bsm
increas
compar
heph
ala
still
remain
lower
wildtyp
sfig
appar
increas
function
minor
may
provid
select
advantag
appar
one
benefit
low
high
affin
variant
mutat
found
clone
virus
either
type
x
measur
presenc
absenc
exogen
hefc
respect
surprisingli
stark
contrast
trial
trial
popul
compris
virus
express
wildtyp
bcov
less
consist
variant
mutat
four
low
receptor
bind
affin
thr
ile
asn
tyr
val
gli
tyr
one
nearwildtyp
bind
affin
pro
leu
except
thr
ile
posit
seen
tabl
consist
previou
find
howev
viru
purif
endpoint
dilut
absenc
exogen
hefc
yield
low
affin
mutant
test
exclus
sfig
variant
trial
popul
equal
replic
fit
condit
appli
odd
result
would
less
first
glanc
two
trial
would
seem
differ
outcom
offer
howev
result
fact
conson
main
differ
speed
viru
popul
increas
evolv
inher
stochast
element
experiment
approach
whether
develop
quasispeci
undergo
slow
track
experi
fast
track
evolut
experi
like
depend
time
advent
first
mutant
viru
properti
instanc
whether
ultralow
like
ile
ser
low
affin
variant
like
asn
ser
find
allow
sever
conclus
confirm
firmli
establish
loss
lectin
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
function
select
mutat
reduc
receptorbind
affin
virion
avid
fc
fusion
protein
biosynthesi
intracellular
transport
nativ
trimer
spike
seemingli
affect
lesser
extent
least
uptak
sarg
cy
vsv
pseudotyp
notic
impair
compar
wildtyp
sfig
still
mutat
alter
infect
pseudotyp
particl
make
less
depend
exogen
hefc
sfig
presum
reduc
avid
trimer
local
misfold
consequenti
disrupt
rb
one
monom
iv
perhap
surprisingli
quasispeci
develop
loss
lectin
function
compens
level
viral
popul
minor
low
affin
variant
constitut
less
swarm
sustain
replic
high
affin
variant
actual
allow
latter
flourish
amplifi
becom
major
phenotyp
protein
coevolv
attain
function
balanc
optim
virion
avid
among
first
mutat
fix
upon
zoonot
introduct
earli
emerg
hethr
asn
substitut
creat
glycosyl
site
rim
lectin
domain
rb
fig
glycan
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
analysi
viru
swarm
aris
target
recombin
show
glycosyl
site
destroy
popul
exclus
ser
phe
substitut
fig
mutat
partial
restor
receptor
bind
receptor
destruct
wildtyp
respect
fig
c
vast
major
virus
newli
introduc
glycosyl
site
retain
instead
mutat
reduc
affin
select
srb
thr
replac
either
ile
seen
fig
tabl
asn
fig
latter
mutat
reduc
affin
wildtyp
viru
clone
endpoint
dilut
yield
three
five
isol
thr
asn
variant
newli
introduc
nglycosyl
site
intact
hethr
asn
furthermor
singl
thr
ile
variant
isol
viru
addit
nglycosyl
site
destroy
thr
asnser
phe
fig
observ
led
us
entertain
possibl
mutat
occur
independ
even
virus
express
low
affin
spike
partial
restor
mutat
would
yet
provid
select
advantag
test
clonal
thr
asnhethr
asn
variant
serial
passag
three
virus
independ
lost
asn
glycosyl
time
salient
ser
phe
substitut
exclus
even
remark
heser
phe
mutant
gain
domin
variant
emerg
restor
affin
near
wildtyp
substitut
asn
either
thr
ser
fig
one
five
clonal
popul
obtain
endpoint
dilut
unfortun
fail
determin
genotyp
technic
reason
ng
analysi
popul
deduc
start
mutant
must
low
affin
leu
pro
variant
like
thr
asnil
variant
describ
quickli
lost
heasn
glycan
heser
phe
substitut
oddli
enough
leu
pro
substitut
detect
ng
preclon
viru
stock
note
howev
mutat
select
twice
independ
trial
rbcovhef
tabl
possibl
aros
spontan
end
point
dilut
procedur
may
vitro
evolut
prove
inform
fig
ng
analysi
passag
popul
result
multistep
propag
show
virus
code
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
order
appear
mutat
effect
protein
function
indic
fix
mere
restor
balanc
attach
catalysisdriven
virion
elut
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
thr
asn
leu
pro
propag
thu
recov
deriv
rapidli
emerg
increas
lectin
esteras
activ
ser
phe
mutat
appar
creat
he
disbal
turn
favor
select
virus
revert
mutat
rais
rb
affin
wildtyp
thr
ile
thr
leu
pro
leu
near
wildtyp
level
thr
ile
ser
leu
thrser
conjointli
find
indic
initi
sharp
reduct
overal
avid
compensatori
loss
function
viru
particl
regain
capac
elud
catalyt
virion
releas
posit
addit
optim
balanc
receptorbind
receptordestruct
system
strive
toward
optim
virion
avid
fig
natur
circumst
setpoint
balanc
would
tailor
condit
met
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
percent
occurr
bcov
mutat
rel
bind
affin
measur
equilibrium
endpoint
solid
phase
bind
assay
fc
fusion
protein
parent
bcov
fc
wildtyp
set
variant
thr
ile
asn
tyr
emerg
experi
see
sfig
affin
rel
wildtyp
shown
comparison
na
applic
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
hemagglutinin
recogn
sialic
acid
receptor
determin
j
virol
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
